9 Stocks and 91 ETFs for diversifying LABD (DIREXION DAILY S&P BIOTECH BEAR 3X SHARES DIREXION DAILY S&P BIOTECH BEAR 3X SHARES)
The least correlated asset to LABD (DIREXION DAILY S&P BIOTECH BEAR 3X SHARES DIREXION DAILY S&P BIOTECH BEAR 3X SHARES) is ETF XBI (STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF). The correlation is -0.9697.
Stocks that lowly correlated with LABD
| Symbol | Name | Market cap | Sector | Industry | Correlation |
|---|---|---|---|---|---|
| BMEZ | BlackRock Health Sciences Term Trust | $1.53B | Financial Services | Asset Management | -0.77 |
| SION | Sionna Therapeutics Inc | $2B | Healthcare | Biotechnology | -0.76 |
| LHAI | Linkhome Holdings Inc | $19M | Real Estate | Real Estate Services | -0.75 |
| KYMR | Kymera Therapeutics Inc | $9.38B | Healthcare | Biotechnology | -0.75 |
| BACC | Blue Acquisition Corp - Class A | $214M | Financial Services | Shell Companies | -0.69 |
| YOUL | Youlife Group Inc | $41M | Consumer Defensive | Education & Training Services | -0.69 |
| EICB | Eagle Point Income Company Inc. 7.75% Series B Term Preferred Stock Due 2028 | $626M | Financial Services | Asset Management | -0.68 |
| JCAP | Jefferson Capital Inc | $1.06B | Financial Services | Credit Services | -0.67 |
| NRIX | Nurix Therapeutics Inc | $2.47B | Healthcare | Biotechnology | -0.67 |